Prognosis

Two Chinese mRNA Covid Vaccines Move Toward Clinical Trials

CSPC Pharma’s vaccine approved for clinical trial in China
China’s regulator has not yet approved any mRNA vaccines

WATCH: Shanghai reported 9,006 daily Covid cases for Sunday as the city begins a new round of mass tests on Monday. Source: Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Tom Hancock

April 3, 2022 at 12:40 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know

A Chinese company said it’s received approval to start clinical trials of a Covid-19 vaccine based on mRNA technology, while local media reported that another domestic company has applied to start a similar trial.